Mengcheng Shen
Molecular Biology · 2015–2017
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 50 citations into it
- Oncology — 42 citations into it
Whom Mengcheng Shen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Mengcheng Shen overall
Papers from Mengcheng Shen's perspective
Ordered by how strongly the researchers Mengcheng Shen trusts endorse each paper. Same corpus, a different order for every researcher.
- A metalloprotease-disintegrin participating in myoblast fusion
- The ADAMs family of metalloproteases: multidomain proteins with multiple functions.
- Catalytic Properties of ADAM19*
- The cysteine-rich domain regulates ADAM protease function in vivo
- Evidence for a Critical Role of the Tumor Necrosis Factor α Convertase (TACE) in Ectodomain Shedding of the p75 Neurotrophin Receptor (p75NTR)*
- Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. (Circulation)
- Regulation of ADAMTS9 Secretion and Enzymatic Activity by Its Propeptide*
- Metalloprotease-Disintegrins: Links to Cell Adhesion and Cleavage of TNFα and Notch
- Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. (Developmental Cell)
- Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells (Circulation Research)
Their papers
- Cardiomyocyte A Disintegrin And Metalloproteinase 17 (ADAM17) Is Essential in Post–Myocardial Infarction Repair by Regulating Angiogenesis (2015) — 46 citations
- Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage. (2017) — 37 citations
- ADAMs family and relatives in cardiovascular physiology and pathology. (2016) — 65 citations